Source:http://linkedlifedata.com/resource/pubmed/id/12692103
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2003-4-14
|
| pubmed:abstractText |
Genetic testing for inherited germ-line mutations associated with cancer susceptibility is an emerging technology in medical practice. Limited information is currently available about physician use of cancer susceptibility tests (CSTs). In 1999-2000, a nationally representative survey was conducted to estimate prevalence of CST use by United States physicians and assess demographic, training, practice setting, and practice patterns associated with use. A stratified random sample of clinicians in eight specialties was selected from a file of all licensed physicians. In total, 1251 physicians, including 820 in primary care and 431 in tertiary care, responded to a 15-min questionnaire by mail, telephone, fax, or Internet (response rate = 71.0%). In the previous 12 months, 31.2% [95% confidence interval (CI), 28.5-33.9] overall, including 30.6% (95% CI, 27.5-33.7) in primary care and 33.4% (95% CI, 27.9-38.9) in tertiary care, had ordered CSTs or referred patients elsewhere for risk assessment or testing. More physicians referred patients elsewhere [26.7% (95% CI, 24.2-29.2)] than directly ordered tests [7.9% (95% CI, 6.3-9.5)]. Factors associated with ordering or referring included practice location in the Northeast [odds ratio (OR), 2.30; 95% CI, 1.46-3.63%], feeling qualified to recommend CSTs (OR, 1.96; 95% CI = 1.41-2.72), receiving CST advertising materials (OR, 1.97; 95% CI, 1.40-2.78%), and most notably, having patients who asked whether they can or should get tested (OR, 5.52; 95% CI, 3.97-7.67%). Lower CST use was associated with not knowing if there were local testing and counseling facilities (OR, 0.39; 95% CI, 0.23-0.66%). These findings underscore the importance of establishing effective clinical approaches to test use and promoting physician education to facilitate communication with patients about cancer genetics.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1055-9965
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
12
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
295-303
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:12692103-Adult,
pubmed-meshheading:12692103-Aged,
pubmed-meshheading:12692103-Female,
pubmed-meshheading:12692103-Genetic Counseling,
pubmed-meshheading:12692103-Genetic Predisposition to Disease,
pubmed-meshheading:12692103-Genetic Testing,
pubmed-meshheading:12692103-Humans,
pubmed-meshheading:12692103-Male,
pubmed-meshheading:12692103-Medicine,
pubmed-meshheading:12692103-Middle Aged,
pubmed-meshheading:12692103-Multivariate Analysis,
pubmed-meshheading:12692103-Neoplasms,
pubmed-meshheading:12692103-Physician's Practice Patterns,
pubmed-meshheading:12692103-Physicians,
pubmed-meshheading:12692103-Prevalence,
pubmed-meshheading:12692103-Professional Practice Location,
pubmed-meshheading:12692103-Questionnaires,
pubmed-meshheading:12692103-Risk Assessment,
pubmed-meshheading:12692103-Specialization,
pubmed-meshheading:12692103-United States
|
| pubmed:year |
2003
|
| pubmed:articleTitle |
Physician use of genetic testing for cancer susceptibility: results of a national survey.
|
| pubmed:affiliation |
National Cancer Institute, Division of Cancer Control and Population Sciences, Bethesda, Maryland 20892-7344, USA. wideroff@nih.gov
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Multicenter Study
|